Teleflex Incorporated $TFX Shares Acquired by Federated Hermes Inc.

Federated Hermes Inc. lifted its stake in Teleflex Incorporated (NYSE:TFX) by 11.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,689 shares of the medical technology company’s stock after acquiring an additional 5,908 shares during the period. Federated Hermes Inc.’s holdings in Teleflex were worth $7,304,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of TFX. Norges Bank bought a new stake in shares of Teleflex in the 2nd quarter worth approximately $65,826,000. Pzena Investment Management LLC purchased a new stake in Teleflex in the 2nd quarter worth approximately $42,149,000. Qube Research & Technologies Ltd boosted its position in Teleflex by 100.1% during the second quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock valued at $71,821,000 after purchasing an additional 303,521 shares during the last quarter. Wedge Capital Management L L P NC acquired a new stake in shares of Teleflex during the 3rd quarter valued at about $26,929,000. Finally, Boston Partners lifted its stake in Teleflex by 112.5% in the second quarter. Boston Partners now owns 380,933 shares of the medical technology company’s stock valued at $45,085,000 after acquiring an additional 201,652 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of TFX stock opened at $104.40 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $184.34. The firm’s 50 day moving average price is $116.10 and its two-hundred day moving average price is $119.64. The stock has a market cap of $4.61 billion, a PE ratio of -14.20, a PEG ratio of 1.36 and a beta of 0.92.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. The firm had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The company’s revenue was up 19.4% compared to the same quarter last year. During the same quarter last year, the business earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is currently -18.50%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on TFX shares. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Truist Financial raised their target price on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. Wells Fargo & Company dropped their target price on Teleflex from $139.00 to $116.00 and set an “equal weight” rating for the company in a report on Thursday. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 price target on shares of Teleflex in a report on Wednesday, December 17th. Two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $139.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.